Big South Bay office building is bought, deal shows huge price plunge
The recent acquisition of the former 23andMe headquarters illustrates the dramatic downfall of commercial property values in Silicon Valley post-pandemic.
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.
23andMe and its user data will soon belong to a pharmaceutical giant
23andMe will continue its DNA testing services following acquisition by Regeneron Pharmaceuticals, ensuring privacy protections and customer data management remain in place.
Bankrupt 23andMe faces scrutiny by U.S. House Committee as government seeks testimony from cofounder
The bankruptcy filing by 23andMe has raised concerns about the potential transfer of genetic data to third-party buyers, prompting a House committee investigation.